CFlores-Lab
banner
labcflores.bsky.social
CFlores-Lab
@labcflores.bsky.social
Passionate scientists leveraging genomics to understand diseases and seeking clinical applications
Preprint alert! Many studies have established the grounds to increase the diversity in catalogs of genetic variation to optimally represent population-specific particularities and to support Personalized Medicine strategies across populations worldwide.
November 27, 2025 at 10:08 PM
Paper alert! Immunocompromised patients could suffer a SARS-CoV-2 infection with viral shedding for long periods of time. Sequencing on serial samples of the patient previously evidenced accelerated viral evolution with accumulation of mutations. www.journalofinfection.com/article/S016...
Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia
In this journal, Walsh and colleagues1 recently reviewed the evidence supporting that immunocompromised patients may remain positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in...
www.journalofinfection.com
November 21, 2025 at 9:47 AM
Today was another great day for @labcflores.bsky.social. We have a new Doctor in town. Kudos @evatosco.bsky.social for such a fantastic defense of your PhD. Hope you enjoyed the day despite the nerves of these past months. Glad to share some of the best moments of the day.
November 20, 2025 at 10:17 PM
Very grateful for the invitation to talk in the World Critical Lung Day (IX Edition; wdcl.com.co) organized by #Fepimcti to share the state-of-the-art in genomics to better characterize infections and how our team leverage these technologies for better care.
November 20, 2025 at 8:08 AM
Reposted by CFlores-Lab
📢 WES and telomere analyses in idiopathic pulmonary fibrosis #IPF patients uncovered pathogenic RTEL1 and NAF1 variants through a robust, clinically useful tiered virtual gene panel workflow. 🧬

Read more in the latest issue of #EJHG ⬇️
www.nature.com/articles/s41...
November 15, 2025 at 1:11 PM
We are delighted to announce that one
@labcflores.bsky.social study led by @aitanaag90.bsky.social has received the Award "II Premios Canarias a la Ciencia de la Salud e Investigación Biomédica" for the best scientific publication of the year. Link to the paper: www.thelancet.com/journals/lan...
Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation
We found non-additive effects between qualifying variants and common risk variants in IPF survival, suggesting distinct disease subtypes and raising the possibility of using PRS to guide sequencing pr...
www.thelancet.com
November 14, 2025 at 7:26 PM
Delighted to share that our manuscript entitled “A tiered strategy to identify relevant genetic variants in familial pulmonary fibrosis: a proof of concept for the clinical practice” is now published in the @ejhg-journal.bsky.social November issue
November 14, 2025 at 7:15 PM
Reposted by CFlores-Lab
I am grateful to CIBERES and CIBERBBN for organizing such an enriching meeting, and to all funding bodies, institutions, and collaborators who made this work possible.

@ciberisciii.bsky.social @labcflores.bsky.social
#CIBERES #CIBERBBN
November 10, 2025 at 4:11 PM
Reposted by CFlores-Lab
Our findings highlight a set of proteins involved in immune regulation and tissue remodelling, which may shed light on the mechanisms driving long-term lung sequelae.
November 10, 2025 at 4:11 PM
Reposted by CFlores-Lab
In this study, we explored whether plasma protein levels measured six months after ICU discharge could serve as biomarkers of interstitial lung disease (ILD) in patients who survived a severe COVID-19.
November 10, 2025 at 4:11 PM
Reposted by CFlores-Lab
During the event, I presented our work titled:
“Interstitial lung disease protein biomarkers in post-COVID patients.”
November 10, 2025 at 4:11 PM
Reposted by CFlores-Lab
Last week, I had the pleasure of attending the Jornadas de Personal Investigador Joven CIBERES–CIBERBBN 2025, an inspiring meeting that brought together young researchers from across Spain to exchange ideas, projects, and challenges in biomedical research.
November 10, 2025 at 4:11 PM
It's been an intense week for us with several of our study results being presented at different research gatherings
November 8, 2025 at 10:25 AM
Reposted by CFlores-Lab

🌎La resistencia a los antimicrobianos es una amenaza a escala global.

🤝En Conexión-AMR tenemos claro que este reto solo puede enfrentarse desde múltiples perspectivas y colaborando entre disciplinas. (1/2)
November 6, 2025 at 10:01 AM
Reposted by CFlores-Lab
What a nice conference with such inspiring speakers @kottond.bsky.social @francypolverino.bsky.social @jennydickens41.bsky.social
Really enjoyed meeting old and new people in the genomics space!
Looking forward to the foreseeable progress in the field
#RespGen25
And that's a wrap on the Respiratory Genomics Conference 2025. Thank you so much to all our attendees for their time, thoughts and inspiration. We'll see you all again in 2027! #RespGen25
November 5, 2025 at 7:20 PM
Happy to share our results and an update of the genetic studies in #ILD in this meeting. @labcflores.bsky.social
October 17, 2025 at 5:12 PM
By now, it would not surprise anyone to understand that there are host genetic variants governing severe infection outcomes.
September 30, 2025 at 11:50 AM
Reposted by CFlores-Lab
Want to better understand what interstitial lung diseases are and what do we aim for with the project PRECISION-ILD funded by @isciiisalud.bsky.social involving the participation of many researchers from Spain and abroad? Check the project's webpage: precisionepid.com
Precision-ILD
precisionepid.com
September 13, 2025 at 7:56 PM
Want to better understand what interstitial lung diseases are and what do we aim for with the project PRECISION-ILD funded by @isciiisalud.bsky.social involving the participation of many researchers from Spain and abroad? Check the project's webpage: precisionepid.com
Precision-ILD
precisionepid.com
September 13, 2025 at 7:56 PM